An innovative care delivery model at Mayo Clinic integrates virtual oversight, remote patient monitoring, mobile health ...
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel ...
Clinical Trials Arena on MSN
START and Trialing collaborate on oncology clinical trials
START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.
In this randomized phase II Lung-MAP nonmatch substudy (S1800A), patients ineligible for a biomarker-matched substudy with NSCLC previously treated with ICI and platinum-based chemotherapy and ...
As hospitals reduced their spending on oncology treatments due to the increasing availability of biosimilars, the reimbursements they received from insurers did not drop at the same rate—allowing h | ...
The Health Management Academy's executive forum recognized alongside ASCO, AACR, and other leading gatherings in ...
The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how effectively the two are integrated.
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will ...
Equity-Insider.com News Commentary -- Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results